T 0429/96 (Serine protease inhibitors/AMGEN) of 31.5.2001

European Case Law Identifier: ECLI:EP:BA:2001:T042996.20010531
Date of decision: 31 May 2001
Case number: T 0429/96
Application number: 86900423.4
IPC class: C07K 7/10
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 39 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: SERINE PROTEASE INHIBITORS AND METHODS FOR ISOLATION OF SAME
Applicant name: Amgen Inc.
Opponent name: Teijin Limited
Board: 3.3.04
Headnote: -
Relevant legal provisions:
European Patent Convention 1973 Art 83
European Patent Convention 1973 Art 54
European Patent Convention 1973 Art 56
Keywords: Admissibility of the grounds of opposition under Article 83 and 56 (yes)
Sufficiency of disclosure (yes)
Novelty (yes)
Inventive steps (yes)
Catchwords:

-

Cited decisions:
T 0301/87
T 0737/90
Citing decisions:
T 0485/18

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960429eu1.html

Date retrieved: 17 May 2021

3 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

Case Law Book: II Conditions to be met by an Application

General Case Law